On June 27, 2023, the Jiangsu Regional Cell Preparation Center, Jiangsu Tuohong Kangheng Pharmaceutical Co., Ltd. Quality Department and R&D Department team visited Genom Biotechnology to conduct an on-site audit of raw material suppliers. Dr. Li Liang, Chairman and CEO of Jinuo Life Health Holding Group, attached great importance to this and expressed a warm welcome and active cooperation.
Guo Yonglin, Vice President of Jinuo Life Health Holding Group, briefly introduced GENOM BIO's development history and business layout in the field of biopharmaceuticals, and GENOM BIO 's quality and process personnel introduced the company's product production, quality control and warehousing processes in detail. Customers were deeply impressed by the company's orderly production process, strict quality control, clean storage environment, and hardworking employees.
Afterwards, the experts of the audit team learned in detail about the operation of our quality management system. From a professional perspective, both parties had a full exchange of opinions on the requirements of the ISO/GMP dual system.
The audit work was successfully completed in a serious, rigorous and professional atmosphere. The audit team of Tuohong Kangheng recognized and affirmed the business strength and management system of GENOM BIO, and also put forward scientific and professional guidance for the next work, laying a solid foundation for further cooperation between the two parties.
As an important raw material in the biopharmaceutical industry, cell culture medium greatly affects product quality. In the future, GENOM BIO will continue to focus on research and development, forge ahead, and help the high-quality development of the biopharmaceutical industry with a positive attitude and spirit of exploration, and become a trustworthy partner of the biopharmaceutical industry!
